Cargando…
Developing a new class of engineered live bacterial therapeutics to treat human diseases
A complex interplay of metabolic and immunological mechanisms underlies many diseases that represent a substantial unmet medical need. There is an increasing appreciation of the role microbes play in human health and disease, and evidence is accumulating that a new class of live biotherapeutics comp...
Autores principales: | Charbonneau, Mark R., Isabella, Vincent M., Li, Ning, Kurtz, Caroline B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142098/ https://www.ncbi.nlm.nih.gov/pubmed/32269218 http://dx.doi.org/10.1038/s41467-020-15508-1 |
Ejemplares similares
-
An engineered bacterial therapeutic lowers urinary oxalate in preclinical models and in silico simulations of enteric hyperoxaluria
por: Lubkowicz, David, et al.
Publicado: (2022) -
Characterization of an engineered live bacterial therapeutic for the treatment of phenylketonuria in a human gut-on-a-chip
por: Nelson, M. Tyler, et al.
Publicado: (2021) -
Perspective: The promise of multi-cellular engineered living systems
por: Kamm, Roger D., et al.
Publicado: (2018) -
Principles for the design of multicellular engineered living systems
por: Aydin, Onur, et al.
Publicado: (2022) -
Engineering Complexity in Bacterial Regulatory Circuits for Biotechnological Applications
por: Westmann, Cauã Antunes, et al.
Publicado: (2018)